NYSE:AIM

Aim Immunotech Stock News

etoro logo Buy AIM
*Your capital is at risk
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
OCALA, FL / ACCESSWIRE / June 29, 2020 / AIM ImmunoTech (NYSE American:AIM), today announced that it has been added to the Russell Microcap® Index, following the annual Russell indexes reconstitution
Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as
Receives clearance from Argentina's FDA to import first shipment of Ampligen® for commercial sale in Argentina AIM 'sets sights' on treating COVID-19 induced chronic fatigue in Argentin
OCALA, FL / ACCESSWIRE / June 15, 2020 / AIM ImmunoTech (NYSE American:AIM), today provided an update on the commercial launch of Ampligen® for the treatment of severe Chronic Fatigue Syndrome (CFS)
OCALA, FL / ACCESSWIRE / June 11, 2020 / AIM ImmunoTech (NYSE American:AIM), today announced that it has filed a provisional patent application for, among other discoveries, the use of its experimenta
It's estimated that 90 percent of staff in the sector have been furloughed
The season looks set to be scrapped
Cycling campaigners want to change the layout of the Firepool development site in Taunton
OCALA, FL / ACCESSWIRE / May 14, 2020 / AIM ImmunoTech (NYSE American:AIM) today announced that the U.S. Food and Drug Administration has authorized the first human trial assessing the safety and effe

What does COVID-19 do to the body?

10:47pm, Thursday, 07'th May 2020
"Three weeks in hell" or a bad cold? What does COVID-19 feel like, and how does your body fight back?
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
OCALA, FL / ACCESSWIRE / April 29, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral dis

BBBY, DVAX among premarket gainers

01:22pm, Tuesday, 28'th Apr 2020
Broadwind Energy (NASDAQ:BWEN) +60%. on $19M order.TrovaGene (NASDAQ:TROV) +44% on new positive results from its ongoing Phase 1b/2 clinical trial of onvansertib in combination with FOLFIRI and Avast
Facebook takes aim at Zoom with video chat upgrade
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE